University of Minnesota College of Veterinary Medicine
University / teaching hospital
5 current cancer treatment or research opportunities
About Minnesota animal cancer research
Minnesota's Animal Cancer Care and Research Program links its veterinary hospital with the Masonic Cancer Center. The Modiano laboratory and clinical teams are widely known for comparative research on lymphoma, bone cancer and hemangiosarcoma.
Cancer types currently listedGlioma, Lymphoma, Mammary Carcinoma, Oral Melanoma
Where visits take placeUniversity of Minnesota Veterinary Medical Center, 1365 Gortner Ave, St Paul, MN 55108
Current options at University of Minnesota College of Veterinary Medicine
Open an option to see who may qualify, locations, costs or coverage, contact details and the official source.
Zika-virus vaccine + autologous tumor-lysate vaccines for high-grade canine glioma
University of Minnesota Canine Brain Tumor Program · USA
Open and enrolling
What is being offered: Two vaccine doses before surgical tumor removal, followed by three postoperative vaccine doses; MRI monitoring every 16 weeks.
Who may qualify: Active tumor required; Planned surgery; Min weight kg: 3; Max weight kg: 45; Single telencephalic glioma on mri; radiation washout: 84 days; immunotherapy washout days: 42 days; surgery washout days: 28 days
Costs / coverage: 🟡 Partially funded. Study covers surgery, postoperative MRI/care and infusions; owner pays pre-enrollment thoracic/abdominal screening and diagnostic brain MRI.
Contact: Canine Brain Tumor Program: cbtp@umn.edu
Location
University of Minnesota Veterinary Medical Center, 1365 Gortner Ave, St Paul, MN 55108
Nanoparticle delivery of anti-tumor genes for high-grade canine glioma
University of Minnesota Canine Brain Tumor Program · USA
Open and enrolling
What is being offered: Surgical tumor removal followed by nanoparticle anti-tumor gene therapy lining the surgical cavity; MRI monitoring every 16 weeks.
Who may qualify: Active tumor required; Planned surgery; Min weight kg: 3; Max weight kg: 45; Single telencephalic glioma on mri; radiation washout: 84 days; immunotherapy washout days: 42 days; surgery washout days: 28 days
Costs / coverage: 🟡 Partially funded. Study covers surgery, postoperative MRI/care and infusions; owner pays pre-enrollment thoracic/abdominal screening and diagnostic brain MRI.
Contact: Canine Brain Tumor Program: cbtp@umn.edu
Location
University of Minnesota Veterinary Medical Center, 1365 Gortner Ave, St Paul, MN 55108
Olaparib plus meloxicam for feline mammary carcinoma
University of Minnesota Veterinary Medical Center · USA
Open and enrolling
What is being offered: Pilot treatment study combining PARP inhibition with meloxicam for measurable feline mammary carcinoma.
Who may qualify: Confirmed cancer diagnosis required; Active tumor required; Min tumor cm: 1
Costs / coverage: 🟡 Partially funded. Screening, study medications and required study visits/labs/imaging are covered; the study also provides a $2,000 surgical credit and up to $1,000 for study-medication complications.
Contact: University of Minnesota Clinical Investigation Center — 612-624-2485; Canine Brain Tumor Program clinical-trials coordinator Sara Pracht
Location
University of Minnesota Veterinary Medical Center, 1365 Gortner Ave, St Paul, MN 55108
University of Minnesota College of Veterinary Medicine · USA
Open and enrolling
What is being offered: Novel adeno-associated virus (AAV) cancer vaccine
Costs / coverage: 🟡 Partially funded. The study covers all study-associated visit costs and provides a $4,000 credit toward local surgery or radiation therapy performed at the University of Minnesota; owners pay any local-therapy cost above the credit.
Contact: University of Minnesota Clinical Investigation Center — 612-624-2485; Canine Brain Tumor Program clinical-trials coordinator Sara Pracht
Location
University of Minnesota Veterinary Medical Center, 1365 Gortner Ave, St Paul, MN 55108
ORBIT: VSV plus anti-PD-1 for canine aggressive lymphoma
University of Minnesota College of Veterinary Medicine · USA
Open and enrolling — Phase 2 VSV plus anti-PD-1
What is being offered: Genetically modified vesicular stomatitis virus (VSV) plus anti-PD-1 checkpoint inhibitor
Who may qualify: Confirmed cancer diagnosis required; Active tumor required; Min weight kg: 7.5; Aggressive lymphoma
May not qualify if: Indolent lymphoma; Alternative herbal medications
Costs / coverage: Owners pay initial diagnostic exam, bloodwork and urinalysis at screening; after enrollment, study-related visits and treatments are covered up to the stated study maximum.
Contact: University of Minnesota Clinical Investigation Center — 612-624-2485; Canine Brain Tumor Program clinical-trials coordinator Sara Pracht
Location
University of Minnesota Veterinary Medical Center, 1365 Gortner Ave, St Paul, MN 55108
A listing here does not mean every pet will qualify. Enrollment can change, and the study team makes the final decision after reviewing your pet’s diagnosis, records and previous treatment.
Have the pathology report, recent imaging and treatment history ready. Ask whether a referral is required, which visits must happen in person and what the study pays for before making travel plans.
